HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$28.11
Day range
$27.75 - $28.99
Year range
$13.57 - $43.72
Market cap
501.17M USD
Avg Volume
645.76K
P/E ratio
5.16
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 101.68M | 176.01% |
Operating expense | 36.08M | 7.42% |
Net income | 59.61M | 5,887.67% |
Net profit margin | 58.63 | 2,193.93% |
Earnings per share | 3.28 | 5,566.67% |
EBITDA | 61.71M | 5,721.70% |
Effective tax rate | 0.62% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 108.38M | 120.72% |
Total assets | 206.74M | 61.00% |
Total liabilities | 124.80M | -21.17% |
Total equity | 81.93M | — |
Shares outstanding | 17.94M | — |
Price to book | 6.15 | — |
Return on assets | 79.83% | — |
Return on capital | 116.35% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 59.61M | 5,887.67% |
Cash from operations | 30.54M | 10,011.59% |
Cash from investing | -23.28M | -312.97% |
Cash from financing | 418.00K | 155.59% |
Net change in cash | 7.68M | -26.72% |
Free cash flow | 55.75M | 10,050.41% |
About
Founded
1996
Headquarters
Website
Employees
163